Swiss Cancer Institute
Clinical trials sponsored by Swiss Cancer Institute, explained in plain language.
-
Could the time of day you get immunotherapy boost its power against melanoma?
Disease control Not yet recruitingThis study looks at whether giving immunotherapy infusions in the morning improves outcomes for people with advanced melanoma. Researchers will compare morning versus afternoon/evening dosing in 108 participants. The goal is to see if aligning treatment with the body's natural im…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Which Pre-CAR-T chemo is safer? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether bendamustine causes fewer severe side effects than the standard fludarabine/cyclophosphamide combination when given before CAR-T cell therapy for B-cell lymphoma. About 92 people will be randomly assigned to one of the two chemotherapy regimens. The main …
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC